M&A Deal Summary |
|
|---|---|
| Date | 2019-06-17 |
| Target | Houston Cyclotron Partners - Cyclotope Radiopharmacy |
| Sector | Life Science |
| Buyer(s) | Sofie |
| Sellers(s) | Houston Cyclotron Partners |
| Deal Type | Divestiture |
SEARCH BY
Sofie is a molecular imaging company combining new PET imaging diagnostics with innovative imaging and synthesis systems to provide researchers and physicians with tools to better investigate the biology of disease. Sofie is based in Dulles, Virginia.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 2 of 2 |
| State: Texas M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2019 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2017-05-11 |
Zevacor Pharma
Noblesville, Indiana, United States Zevacor Pharma is a developer, manufacturer and distributor of PET radiopharmaceutical products and supporting services used in molecular imaging in the U.S. Zevacor has a unique product portfolio and pipeline of diagnostic tracers aimed at advancing the development of the global movement towards personalized medicine and making molecular imaging a major discipline in healthcare. |
Buy | - |
Houston Cyclotron Partners LP is a company dedicated to producing high-quality radiopharmaceutical and radioisotopes for nuclear medicine and diagnostic imaging communities. Cyclotope was designed to meet the current demands of the molecular imaging community as well as to advance the development of next-generation PET tracers.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: Texas M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2019 M&A | 1 of 1 |
